Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1687-8329
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease ; volume:56 ; number:1 ; day:13 ; month:2 ; year:2020 ; pages:1-6 ; date:12.2020
The Egyptian journal of neurology, psychiatry and neurosurgery ; 56, Heft 1 (13.2.2020), 1-6, 12.2020
- Creator
-
Shaheen, Hala
Sobhy, Sayed
El Mously, Sherine
Abuomira, Marwa
Mansour, Mohamed
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41983-020-0159-7
- URN
-
urn:nbn:de:101:1-2020051123231007161852
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shaheen, Hala
- Sobhy, Sayed
- El Mously, Sherine
- Abuomira, Marwa
- Mansour, Mohamed
- SpringerLink (Online service)
Other Objects (12)
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance